MedPath

Comparison of Staples Versus Subcuticular Suture in Class III Obese Women Undergoing Cesarean Delivery

Not Applicable
Completed
Conditions
Obesity, Severe
Cesarean Section
Interventions
Device: Absorbable subcuticular suture
Device: Stainless steel staples
Registration Number
NCT02466776
Lead Sponsor
MemorialCare Health System
Brief Summary

The purpose of this study is to determine the optimal skin closure technique (staples versus subcuticular suture) at the time of cesarean delivery in Class III obese women with body mass index (BMI) of \>/= 40kg/m2.

Detailed Description

A. To assess the rate of wound complications with staples versus subcuticular suture closure in women with a BMI of ≥ 40 kg/m2 undergoing cesarean delivery (CD).

B. No difference was observed in wound complication rates between staples and subcuticular suture skin closure in women with a BMI ≥ 40 kg/m2 undergoing cesarean delivery (CD).

C. At this time, optimal skin closure method in obese women with BMI ≥ 40 kg/m2 undergoing cesarean delivery remains unknown. More work is needed in this area to help reduce the complication rate in this very high-risk population.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
238
Inclusion Criteria
  1. Women > 18 years old undergoing cesarean delivery (CD)
  2. BMI of >/= 40 kg/m2 as determined by height and weight reported during their admission
  3. Live gestation 23 weeks or greater
  4. Women who are able to follow-up 7-14 days after hospital discharge for a visual wound check.
Exclusion Criteria
  1. Active lupus flare
  2. HIV/AIDS
  3. Current treatment for cancer or h/o radiation to the abdomen/pelvis
  4. Hypersensitivity to steri-strips

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Absorbable subcuticular SutureAbsorbable subcuticular suturePatients will receive absorbable subcuticular suture for skin closure at time of cesarean delivery (CD).
Stainless steel staplesStainless steel staplesPatients in this arm will receive stainless steel staples for skin closure at time of cesarean delivery (CD).
Primary Outcome Measures
NameTimeMethod
Composite Wound Complication at Hospital Discharge and 2 Weeks PostpartumAt hospital discharge, at 2 weeks postpartum and at 6 weeks postpartum

Rate of wound complications defined as composite wound complication, which includes infection requiring antibiotics, hematoma, seroma, separation or disruption, and/or readmission to the hospital for wound concerns.

Secondary Outcome Measures
NameTimeMethod
Number of Participants With Blood TransfusionAt time of surgery and hospitalization

Date were analyzed with independent t, X2 and Fisher's exact tests, where applicable

Number of Participants Receiving Postpartum Prophylactic AnticoagulationDuring hospitalization

Date were analyzed with independent t, X2 and Fisher's exact tests, where applicable

Patient Pain Score (From 1 to 10)Within 2 weeks postpartum

Patients' pain associated with their wound within 7-14 days after hospital discharge using a self-administered questionnaire that asked patients to rate their pain on a scale of 0 (no pain) to 10 (worst pain).

Number of Participants With 5 Minute Apgar Score <7At time of delivery

Date were analyzed with independent t, X2 and Fisher's exact tests, where applicable The Apgar score, developed by Virginia Apgar describes the condition of the newborn infant immediately after birth and, when properly applied, is a tool for standardized assessment 18. It also provides a mechanism to record fetal-to-neonatal transition. This scoring system provided a standardized assessment for infants after delivery. The Apgar score comprises five components: 1) color, 2) heart rate, 3) reflexes, 4) muscle tone, and 5) respiration, each of which is given a score of 0, 1, or 2. The Apgar score ranges from 0 (lowest, poor outcome) to 10 (highest, good outcome).

Total Length of Hospital StayAt time of surgery and hospitalization

Date were analyzed with independent t, X2 and Fisher's exact tests, where applicable

Number of Participants According to Skin IncisionAt time of surgery and hospitalization

Date were analyzed with independent t, X2 and Fisher's exact tests, where applicable

Operating Surgeon LevelAt time of surgery

Date were analyzed with independent t, X2 and Fisher's exact tests, where applicable

Surgical Assistant LevelAt time of surgery

Date were analyzed with independent t, X2 and Fisher's exact tests, where applicable

Change in Hemoglobin (Pre-delivery and Post-delivery)At time of surgery (pre-delivery) and post-delivery

Date were analyzed with independent t, X2 and Fisher's exact tests, where applicable

Patient Satisfaction With Wound Healing and AppearanceAt time of hospital discharge and at 2 weeks postpartum

Patients' satisfaction with the healing of their wound within 7-14 days after hospital discharge using a self-administered questionnaire that asked patients to rate their overall satisfaction with their wound healing and appearance (1=least satisfied, 10=most satisfied). Patients were also asked to rate their concern regarding their wound healing (1= least concerned and 10 = most concerned).

Total Operative TimeAt time of surgery and hospitalization

Date were analyzed with independent t, X2 and Fisher's exact tests, where applicable

Total Blood LossAt time of surgery

Date were analyzed with independent t, X2 and Fisher's exact tests, where applicable

Neonatal BirthweightAt time of delivery

Date were analyzed with independent t, X2 and Fisher's exact tests, where applicable

Trial Locations

Locations (4)

University of California, Irvine

🇺🇸

Orange, California, United States

Long Beach Memorial Care Center for Women at Miller Children's Hospital Long Beach and Long Beach Memorial Hospital

🇺🇸

Long Beach, California, United States

Long Beach Memorial Care Center for Women at Miller Children's Hospital Long Beach

🇺🇸

Long Beach, California, United States

Long Beach Memorial Care Center

🇺🇸

Long Beach, California, United States

© Copyright 2025. All Rights Reserved by MedPath